ClinicalTrials.govpublic full text
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
cancer, gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805671
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.